Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $185.5M $129.0M $170.6M $163.2M $44.5M $75.6M $66.3M $41.7M
Accounts Receivable $146.8M $153.4M $173.0M $153.3M $99.7M $91.8M $84.7M $82.6M
Inventory $144.3M $190.8M $189.3M $133.8M $122.3M $100.7M $95.1M $86.0M
Total Current Assets $604.6M $576.9M $589.2M $585.9M $626.8M $591.5M $537.4M $449.5M
Property, Plant & Equipment $329.8M $339.1M $277.1M $198.7M $110.6M $100.5M $78.7M $74.8M
Goodwill $1.05B $1.06B $2.14B $2.14B $142.7M $131.5M $110.3M $103.6M
Intangible Assets (Excl. Goodwill) $1.32B $1.41B $1.51B $1.59B $92.1M $76.8M $51.4M $52.1M
Total Assets $3.35B $3.44B $4.55B $4.55B $992.9M $920.2M $797.2M $695.7M
Liabilities
Accounts Payable $79.1M $79.6M $83.1M $76.7M $34.6M $23.9M $25.7M $19.1M
Total Current Liabilities $158.2M $174.0M $154.3M $145.5M $77.8M $53.6M $48.5M $38.3M
Long-Term Debt $793.7M $874.8M $888.4M $885.4M — — — —
Total Liabilities $1.25B $1.37B $1.40B $1.42B $105.6M $79.8M $72.0M $57.8M
Stockholders' Equity
Retained Earnings $-544.3M $-536.4M $555.6M $565.0M $587.9M $539.6M $478.7M $419.2M
Total Stockholders' Equity $2.09B $2.07B $3.14B $3.13B $887.4M $840.4M $725.2M $637.9M
← Newer Page 1 of 3 Older →